Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Oncology

Takeda Pharmaceutical Company Limited

More Like This

Takeda Announces New Assignments of Directors

Takeda Announces Chief Financial Officer Succession

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries

Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products

Proposals of the Shareholders' Nomination Board to Stora Enso Oyj's Annual General Meeting 2024